Protagenic Therapeutics, Inc. (PTIX)
0.59
+0.05
(+9.26%)
USD |
OTCM |
Jan 16, 16:00
Protagenic Therapeutics EPS Diluted (Quarterly): -0.4702 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8695M |
| Total Expenses (Quarterly) | 0.8695M |
| Enterprise Value | 1.623M |
| Earnings Yield | -1.34K% |
| Normalized Earnings Yield | -1299.19 |